VIE •
Healthcare •
Biotechnology •
Quote as of 06/26/2026 17:32
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeVIE
Market Capitalization2,626.51 mln
Float56.67 mln
Earnings Date05/07/2026
EPS
11.96
Robust
P / E
3.17
Deeply undervalued
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
145
Highly suspicious
Relative Strength
31
/ 100
Underperforming
Debt / Equity
0.03
Debt-free
Business Description
Zealand Pharma is a Danish biotechnology company focused on developing and commercializing medicines built from peptides, with operations in both Denmark and the United States. Its current products address serious conditions such as severe low blood sugar, short bowel syndrome, and congenital hyperinsulinism. Founded in 1997 and headquartered in Søborg, Denmark, the company continues to advance several treatments through late-stage clinical development.
